Speakers

Meet Our Esteemed Speakers

Explore the key opinion leaders and renowned academic experts who bring unparalleled knowledge and thought leadership to our annual events.

Formulation & Delivery Speakers

25 - 26 April 2024 | London, UK

Formulation & Delivery 2024

Declan Lowney
Director of Stability Sciences,
Janssen R&D
Kajsa Rådevik
Associate Director CMC Regulatory Affairs,
AstraZeneca
Naila El Kechai
Head of Biologics Formulation,
Sanofi
Paul Marshall
Regulatory Affairs Director,
Jazz Pharmaceuticals
Sam Nash
Associate Principal Scientist,
AstraZeneca

All Speakers

Amal Ali Elkordy
Professor,
University of sunderland
Andrew Feilden
Director Analytical Science,
Bicycle TX
Annette Vinter Heydenreich
scientist,
www.symphogen.com
Asif Ahmed
Founder & Executive Chairman,
MirZyme Therapeutics Limited
Ben Forbes
Professor of Pharmaceutics,
King's College London
Cees Van Rijn
Professor,
University of Amsterdam
Charley Wu
Professor of Chemical Engineering,
University of Surrey
Chris Broomell
Head of Analytical Development,
Omega Therapeutics
Chris Cardon
Founder Ziphius Vaccines,
Ziphius Vaccines
Christopher Locher
Chief Executive Officer,
Versatope Therapeutics
Covadonga Paneda
Chief Operating Officer,
Altamiratherapeutics
Dan Bach Kristensen
Scientific Director,
Symphogen
Daniel Tondera
Head of Biology,
Pantherna Therapeutics GmbH
David Workman
Associate Principal Scientist,
AstraZeneca
Elena Sanna
Associate Principal Scientist,
Sixfold Bioscience
Elizabeth Ogden
Process Engineer,
AstraZeneca
Estelle Beguin
Director Technology Research,
Ethris GmbH
Florian Rosenthal
Senior Scientist,
F. Hoffman - La Roche Ltd.
Hyunhong James Min
Senior Scientist,
University of Oxford
Ijeoma Uchegbu
Professor,
University College London
Ildikó Terebesi
Managing Director,
INVITE
Janis Shute
Scientific Director,
University of Portsmouth
Jens Twellmeyer
Associate Director Science & Technology,
Novartis
Jérôme Mantanus
Head of Materials Science,
UCB Pharma
Jonathan Reid
Professor of Physical Chemistry and Director of the EPSRC,
University of Bristol
Juha Monkare
Senior Scientist,
Johnson & Johnson
Kamalinder K Singh
Professor of Pharmaceutical Technology and Drug Delivery,
University of Central Lancshire
Koen Raemdonck
Professor,
Ghent University
Mahnoush Bahjat
Associate Director,
AatraZeneca
Martinus Capelle
Scientific Director,
Johnson & Johnson
Maurits Kleijnen
Head of Research,
Intract Pharma
Meike Harms
Lead Scientist,
Merck Healthcare KGaA
Nagy Habib
Lead Clinician and Head of the Department,
Imperial College London
Nathalie Wauthoz
Professor,
Universite Libre de Bruxelles
Per-Olof Wahlund
Specialist,
Novo Nordisk A/S
Philip Rye
Chief Scientific Officer,
AlgiPharma AS
Richard Storey
Principal Scientist,
AstraZeneca
Rikke Dueholm
Senior Scientist,
AstraZeneca
Shayoni Dutta
Principal Data Scientist,
GSK
Simone Vecchi
Cmc leader,
Jnj
Sophie Janbon
Director,
AstraZeneca
Stephen Pham
Senior Vice President,
Avalyn Pharma Inc.
Sune Andersen
Associate Director,
Janssen Pharmaceuticals
Supriyadi Hafiz
Senior Scientist,
Merck Life Science KGaA
Tjasa Vrlinic
Principal Investigator,
Medincell
Venkatesh Teja Banala
Biopharmaceutics Investigator,
GSK
Vincent Ling
Senior Director,
Takeda Pharmaceuticals
Yngve Mikkelsen
Chief Marketing Officer,
AlgiPharma
Yogeshwar Bachhav
Director,
AiCuris Anti-infective Cures AG

16 - 17 October 2024 | San Diego, CA, USA

Formulation & Delivery US 2024

Jamie Tsung
Director, Head of DP Formulation,
Alnylam Pharmaceuticals
Joshua Ziel
Chief Operating Officer,
Aerami
Julie Zhu
Scientific Director,
GSK
Justin Cohen
Director,
Pfizer
Rachel Groppo
Director, Lead saRNA Team,
Johnson & Johnson Innovative Medicines
Robert J Duff
VP Chemistry,
Switch Therapeutics, Inc.

All Speakers

Amish Patel
VP of Technical Operations,
Calidi Biotherapeutics
Ash Dugar
Senior Vice President,
Dyne Therapeutics
Brad Niles
Chief Executive Officer,
ARIZ Precision Medicine
David Loynd
President and Chief Executive Officer,
EnduRx Pharmaceuticals Inc.
David M Jackson
Chief Executive Officer,
Ceria Therapeutics
Deepak Sampath
Senior Vice President, Head of Research,
Ultragenyx Gene Therapy
Evgenyi Shalaev
Executive Director, Pharmaceutical Development,
AbbVie
Irvin Mayers
Professor,
University of Alberta
Jacques Van Dam
VP, Medical Affairs,
Rani Therapeutics, Inc.
James Ferguson
Chief Medical Officer,
Matinas BioPharma
John Gleeson
Associate Principal Scientist,
Merck & Co.
Liang Huang
Professor,
Oregon State University
Lynn Kirkpatrick
Chief Executive Officer,
Ensysce Pharmaceuticals
Marine Hatit
Senior Scientist,
Prime Medicine
Matt Levy
VP of Exploratory Research,
Creyon Bio
Niren Murthy
Professor,
University of California, Berkeley
Paul Peng
VP, Head of CMC,
Korro Bio
Peter Petrochenko
Associate Director of Regulatory Strategy,
Regeneron
Pratik Saha
Global Head, Biopharmaceutics, Drug Product Development,
GSK
Sudip Das
Distinguished Professor,
Butler University
Vivek Gupta
Associate Dean & Associate Professor,
St. John's University
Yuchen Fan
Principal Scientist,
Genentech
Zdravka Medarova
Chief Scientific Officer,
TransCode Therapeutics, Inc.
Zhe Wu
Senior Scientist,
Janssen Pharmaceutical Companies of Johnson & Johnson

June 2025 | Basel, Switzerland

Formulation & Delivery 2025

Speakers for Formulation & Delivery 2025 will be revealed here in the coming weeks